Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies
Antonietta Anatriello, Valerio Liguori, Cecilia Cagnotta, Ciro Pentella, Cristina Scavone, Annalisa Capuano, Barbara Rinaldi · 2026
Read Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies by Antonietta Anatriello, Valerio Liguori, Cecilia Cagnotta, Ciro Pentella, Cristina Scavone, Annalisa Capuano, Barbara Rinaldi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13269103.txt.
Description
Antonietta Anatriello and co-authors pool in 2026 observational evidence on whether popular diabetes and weight drugs raise the risk of eye damage. Concerns cover retinal disease, glaucoma, and a rare optic nerve stroke. Their meta-analysis gathered twenty-eight observational studies in people with diabetes, comparing these GLP-1 drugs with other diabetes treatments.
No outcome showed a clear increase in risk with the drugs. Rates of the optic nerve event, glaucoma, and new or worsening retinal disease all landed close to the comparison groups. The studies, however, disagreed strongly with one another, which weakens certainty in the pooled numbers. The authors conclude that monitoring eyes during treatment remains wise while the reassuring signal is tested in better controlled research.
Catalog record
| CREATOR | Antonietta Anatriello, Valerio Liguori, Cecilia Cagnotta, Ciro Pentella, Cristina Scavone, Annalisa Capuano, Barbara Rinaldi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |